Results 51 to 60 of about 107,836 (304)

Role of positive glucose challenge test only versus oral glucose tolerance test in pregnancy outcome: a comparative study

Journal of Pathology of Nepal, 2019
Background: Gestational diabetes mellitus is defined as any degree of glucose intolerance which is first recognized during pregnancy and is associated with a number of adverse perinatal outcomes, such as neonatal hypoglycemia, macrosomia with an ...
Neha Homagai, Nirajan Mainali, Sikha Rijal   +2 more
doaj   +1 more source

Predictive Value of Fasting Plasma Glucose on First Antenatal Visit before 20 Weeks of Gestation to Diagnose Gestational Diabetes Mellitus [PDF]

Journal of Clinical and Diagnostic Research, 2018
Introduction: Gestational Diabetes Mellitus (GDM) is an important public health concern due to its association with adverse foetomaternal outcome. Steadily increasing prevalence necessitates screening and early treatment of women at risk of developing ...
Manisha Sharma, K Nayanisri, Rekha Jain, Rajiv Ranjan   +3 more
doaj   +1 more source

Evaluation of a Self-Administered Oral Glucose Tolerance Test [PDF]

Diabetes Care, 2013
OBJECTIVE To assess the feasibility of using a disposable, self-administered, capillary blood sampling oral glucose tolerance test (OGTT) device in a community setting. RESEARCH DESIGN AND METHODS Eighteen healthy and 12 type 2 diabetic volunteers ...
Bethel, M, Price, H, Sourij, H, White, S, Coleman, R, Ring, A, Kennedy, I, Tucker, L, Holman, R   +8 more
openaire   +2 more sources

Engineering Immunoregenerative Therapy via an Immunomodulatory Binary Pharmacology Hydrogel Depot for Prolonged Allograft Survival

Advanced Science, EarlyView.
An immunomodulatory hydrogel (iGEL) forms spontaneously upon subcutaneous injection, acting as a tissue‐adhesive depot. It releases anti‐rejection and regenerative agents in response to inflammation, suppressing T‐cell activity, promoting vascular repair, and restoring allograft function without systemic immunosuppression.
Ning Wang, Ruiqi Sun, Yang Fu, Zhonghan Wu, Xinyu Tong, Hong Tang, Wentao Zhao, Zhi Liang, Jintao Zheng, Yanan Guan, Ke Zhou, Penghong Song, Shusen Zheng, Hangxiang Wang, Haiyang Xie   +14 more
wiley   +1 more source

Levels of blood glucose and blood insulin during an oral glucose tolerance test. [PDF]

, 2013
A) Blood glucose levels during an oral glucose tolerance test in male wt mice (open circles) and male hSAA1 mice (filled squares) fed with HFD. B) Blood glucose area under the curve (AUC) in male mice fed with HFD.
Kajsa Sjöholm (351309), Sofie Ahlin (351308), Bob Olsson (307393), Maja Olsson (351306), Per-Arne Svensson (157540)   +4 more
core   +1 more source

The impact of media influence on pregnant women's perceptions of oral glucose tolerance tests in primary health care settings

Turkish Journal of Family Practice
Objective: Screening for gestational diabetes mellitus with the oral glucose tolerance test is recommended between the 24th and 28th weeks of pregnancy.
Hatice Cemre Güven, Funda Salgür, Büşra Cerlet, Rabia Esra Kut, Altuğ Kut   +4 more
doaj   +1 more source

Engineering Approaches to Modify Immunomodulatory Functions of Mesenchymal Stromal Cells (MSCs): Tissue Regeneration and Clinical Application

Advanced Science, EarlyView.
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang, Kejia Li, Ning Wang, Zhen Li, Zhiyong Zhang, Rocky S. Tuan, Yangzi Jiang   +6 more
wiley   +1 more source

Glucose values during oral glucose tolerance test (OGTT) in the presence and absence of metformin. [PDF]

, 2015
Shown are mean ± standard deviation for A) blood glucose (mmol/L) prior to and during the SUGAR-MGH oral glucose tolerance test (OGTT) stratified by participants who took no metformin doses (blue dashed line with blue circles) and participants who took ...
Alisa K. Manning (110227), Amelia Lanier (713061), Sabina Q. Khan (713064), Richard W. Grant (713075), Andrew Taylor (135110), Varinderpal Kaur (713069), Chunmei Huang (124731), Maegan Harden (713070), Ling Chen (25698), Liana K. Billings (713053), Allan F. Moore (713068), Natalia Colomo (590447), Rachel J. Ackerman (713063), Laurel Garber (713066), Rebecca R. Fanelli (713060), Margo S. Hudson (713077), Geoffrey A. Walford (713051), Alicia M. Hernandez (713059), Jaclyn Davis (713057), Janet Lo (713073), Rosa Bui (713065), Katherine R. Littleton (713058), Bindu Chamarthi (713055), Allison Goldfine (713076), A. Sofia Warner (713056), Deborah Wexler (713071), Jose C. Florez (114792), Rita M. McCarthy (713072), Paul Huang (229892), Elliot S. Stolerman (713067), Marlene Fernandez (713054), Jennifer N. Todd (713052), Corinne Barbato (713062), Melissa K. Thomas (713074)   +33 more
core   +1 more source

Comparison of Glucose and Satiety Hormone Response to Oral Glucose vs. Two Mixed-Nutrient Meals in Rats

Frontiers in Nutrition, 2018
The obesity epidemic is driving interest in identifying strategies that enhance appetite control by altering the secretion of hormones that regulate satiety and food intake.
Danielle T. Vannan, Marc R. Bomhof, Raylene A. Reimer, Raylene A. Reimer   +3 more
doaj   +1 more source

Counterpoint: The Oral Glucose Tolerance Test Is Superfluous [PDF]

Diabetes Care, 2002
The oral glucose tolerance test (OGTT) has been used in clinical medicine for nearly 90 years (1). As heretical as this may sound, it is time for it to be retired. It no longer provides unique and important clinical information that cannot be obtained by other means.
openaire   +2 more sources